Search details
1.
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials.
Lancet Oncol
; 21(4): 531-540, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32105622
2.
Correction: A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer.
Br J Cancer
; 121(5): 429-430, 2019 Aug.
Article
in English
| MEDLINE | ID: mdl-31350526
3.
A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer.
Br J Cancer
; 120(2): 183-189, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30531832
4.
Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer.
Invest New Drugs
; 37(2): 315-322, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30191522
5.
A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors.
Oncology
; 97(2): 102-111, 2019.
Article
in English
| MEDLINE | ID: mdl-31230047
6.
Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease.
Lancet Oncol
; 19(3): e151-e160, 2018 03.
Article
in English
| MEDLINE | ID: mdl-29508762
7.
First-in-human phase I dose escalation study of MK-8033 in patients with advanced solid tumors.
Invest New Drugs
; 36(5): 860-868, 2018 10.
Article
in English
| MEDLINE | ID: mdl-29376210
8.
Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer.
Invest New Drugs
; 36(6): 1158, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30334109
9.
An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204).
Oncology
; 94(1): 39-46, 2018.
Article
in English
| MEDLINE | ID: mdl-29040974
10.
NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018.
J Natl Compr Canc Netw
; 16(6): 693-702, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29891520
11.
Current Concepts in the Treatment of Resectable Pancreatic Cancer.
Curr Oncol Rep
; 20(5): 39, 2018 03 26.
Article
in English
| MEDLINE | ID: mdl-29582218
12.
A Phase Ib Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advanced or Metastatic Cancers with Mutant KRAS.
Oncologist
; 22(9): 1024-e89, 2017 09.
Article
in English
| MEDLINE | ID: mdl-28592615
13.
Academic Cancer Center Phase I Program Development.
Oncologist
; 22(4): 369-374, 2017 04.
Article
in English
| MEDLINE | ID: mdl-28314841
14.
Phase II study of the Multikinase inhibitor of angiogenesis, Linifanib, in patients with metastatic and refractory colorectal cancer expressing mutated KRAS.
Invest New Drugs
; 35(4): 491-498, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28353122
15.
Neuroendocrine tumors, version 1.2015.
J Natl Compr Canc Netw
; 13(1): 78-108, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25583772
16.
Enabling a genetically informed approach to cancer medicine: a retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panel.
Oncologist
; 19(6): 616-22, 2014 Jun.
Article
in English
| MEDLINE | ID: mdl-24797823
17.
Phase 1/2 study of KRN330, a fully human anti-A33 monoclonal antibody, plus irinotecan as second-line treatment for patients with metastatic colorectal cancer.
Invest New Drugs
; 32(4): 682-90, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24691674
18.
Treatment of metastatic pancreatic adenocarcinoma: a review.
Oncology (Williston Park)
; 28(1): 70-4, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-24683721
19.
Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design.
Ann Surg Oncol
; 20(8): 2787-95, 2013 Aug.
Article
in English
| MEDLINE | ID: mdl-23435609
20.
Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement.
HPB (Oxford)
; 15(2): 106-15, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23297721